These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20680233)

  • 21. Antiprothrombin antibody testing: detection and clinical utility.
    Oku K; Atsumi T; Amengual O; Koike T
    Semin Thromb Hemost; 2008 Jun; 34(4):335-9. PubMed ID: 18814066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG; Smith SA
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions.
    Ulcová-Gallová Z; Bouse V; Krizanovská K; Balvín M; Rokyta Z; Netrvalová L
    Int J Fertil Womens Med; 2001; 46(6):304-8. PubMed ID: 11795690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laboratory examinations in antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and classification of the antiphospholipid syndrome.
    Gómez-Puerta JA; Cervera R
    J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.
    Bertolaccini ML; Amengual O; Atsumi T; Binder WL; de Laat B; Forastiero R; Kutteh WH; Lambert M; Matsubayashi H; Murthy V; Petri M; Rand JH; Sanmarco M; Tebo AE; Pierangeli SS
    Lupus; 2011 Feb; 20(2):191-205. PubMed ID: 21303836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions.
    Favaloro EJ; Wong RC
    Semin Thromb Hemost; 2008 Jun; 34(4):389-410. PubMed ID: 18814073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.
    Chen DY; Tzang BS; Chen YM; Lan JL; Tsai CC; Hsu TC
    Clin Chim Acta; 2010 Aug; 411(15-16):1084-9. PubMed ID: 20385113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
    Pengo V; Ruffatti A; Legnani C; Gresele P; Barcellona D; Erba N; Testa S; Marongiu F; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    J Thromb Haemost; 2010 Feb; 8(2):237-42. PubMed ID: 19874470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical consequences of antiphospholipid antibodies.
    Derksen RH; de Groot PG
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnosis of the antiphospholipid syndrome.
    Pengo V; Ruffatti A; Iliceto S
    Pathophysiol Haemost Thromb; 2006; 35(1-2):175-80. PubMed ID: 16855367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
    J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
    Miyakis S; Lockshin MD; Atsumi T; Branch DW; Brey RL; Cervera R; Derksen RH; DE Groot PG; Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA
    J Thromb Haemost; 2006 Feb; 4(2):295-306. PubMed ID: 16420554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-beta2-glycoprotein I antibodies--when and how should they be measured?
    Reber G; de Moerloose P
    Thromb Res; 2004; 114(5-6):527-31. PubMed ID: 15507287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference in antiphospholipid antibody assays.
    Lakos G
    Semin Thromb Hemost; 2012 Jun; 38(4):353-9. PubMed ID: 22618529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.